Many therapeutic advances have been made in the field of melanoma recently, leading to new challenges for the nurse working to manage side effects and educate/engage patients. This activity is designed to assist you in incorporating the Care Step Pathways and other tools of the Melanoma Nursing Initiative (TheMelanomaNurse.org) in clinical practice. We hope this activity helps you learn how to use these resources/tools more effectively in identifying and managing the side effects of melanoma therapeutics. Your efforts should help patients stay on therapy and achieve better outcomes.
Release Date: January 24, 2018
Expiration Date: January 23, 2019
Estimated Time to Complete the Activity: 2.75 hrs
Media: Interactive, text-based activity
Upon completing this activity, the participant should be better able to:
This activity is targeted primarily to nurse practitioners, registered nurses, and physician assistants. It will also include the secondary audiences who care for patients with melanoma (including emergency department clinicians, oncologists, and primary care doctors).
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine; Terranova Medica, LLC; and AIM at Melanoma Foundation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.7 contact hours. Designated for 2.4 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of commercial interest.
The following indicates the disclosure declaration information and the nature of those commercial relationships:
Krista M. Rubin, RN, MS, FNP-BC (Chair)
CONSULTING FEES:
Merck, EMD-Serono, and Novartis
Lisa A. Kottschade, APRN, MSN, CNP
CONSULTING FEES:
Genentech
CONTRACTED RESEARCH:
Bristol-Myers Squibb
Suzanne McGettigan, MSN, CRNP, ANP-BC, AOCN
SPEAKERS’ BUREAUS:
Bristol-Myers Squibb, Genentech, Merck and Co., Inc., and Novartis Pharmaceuticals
Virginia Seery, RN, MSN, ANP-BC
NOTHING TO DISCLOSE
The planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP, at PIM; Lisa Tushla, PhD, H(ASCP), at Terranova Medica, LLC; the planners and managers at AIM at Melanoma Foundation; and Michael L. Coco, PhD, at Coco Communications, Inc., have nothing to disclose.
There are no fees for participating and receiving CME/CE credit for this activity. During the period January 24, 2018 through January 23, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please follow the steps below:
Internet
To participate, you will need access to a computer (either MAC or PC), tablet, or smart phone, with a Chrome (version 22.0.1229.94 or greater) web browser, Firefox (version 3.6 or greater) web browser or an Internet Explorer (version 8.0 or greater) web browser, JavaScript enabled, connected to the Internet (high speed connection preferred).
Terranova Medica, LLC, and PIM are committed to protecting the privacy of those who choose to participate in activities on aimatcancerce.org. This information below describes our security policies for safeguarding personal information as well as the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of personal information
Terranova Medica, LLC, and PIM do not transfer, sell, or share personal information with outside parties. We will not disclose the information unless required in a legal proceeding.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There is no charge for this activity.
Jointly provided by Postgraduate Institute for Medicine; Terranova Medica, LLC; and AIM at Melanoma Foundation.
This activity is supported by an independent educational grant from Merck & Co., Inc.
For further information, contact Tom Davis by telephone (877-276-4523), fax (805-648-8070), or email (tdavis@terranovamedica.com).
If you have any questions regarding the CME/CE certification for this activity, please contact Postgraduate Institute for Medicine at: inquiries@pimed.com or (303) 799-1930.
Copyright © 2018 AIM at Melanoma, and Terranova Medica.